Keitaro Omori, Hiroki Kitagawa, Kakuhiro Yamaguchi, Shinjiro Sakamoto, Yasushi Horimasu, Takeshi Masuda, Shintaro Miyamoto, Taku Nakashima, Hiroshi Iwamoto, Kazunori Fujitaka, et al. Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan. Journal of Infection and Chemotherapy. 2023. 29. 9. 875-881
Nakashima, Taku, Omori, Keitaro, Namba, Masashi, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Miyamoto, Shintaro, Iwamoto, Hiroshi, Fujitaka, Kazunori, et al. Serum and bronchoalveolar lavage fluid levels of soluble B7H3 in patients with interstitial lung diseases. RESPIRATORY MEDICINE. 2023. 212
Tanahashi, Hiroki, Yamaguchi, Kakuhiro, Kurose, Koji, Nakao, Satoshi, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Miyamoto, Shintaro, Nakashima, Taku, Iwamoto, Hiroshi, et al. Predictive value of serum high-mobility group box 1 levels for checkpoint inhibitor pneumonitis. RESPIROLOGY. 2023. 28. 4. 380-388
Takeda, Masayuki, Shimokawa, Mototsugu, Nakamura, Atsushi, Nosaki, Kaname, Watanabe, Yasutaka, Kato, Terufumi, Hayakawa, Daisuke, Tanaka, Hiroshi, Takahashi, Toshiaki, Oki, Masahide, et al. A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy. LUNG CANCER. 2023. 177. 44-50
Miura, Shinichiro, Iwamoto, Hiroshi, Omori, Keitaro, Yamaguchi, Kakuhiro, Sakamoto, Shinjiro, Horimasu, Yasushi, Masuda, Takeshi, Miyamoto, Shintaro, Nakashima, Taku, Fujitaka, Kazunori, et al. Preserved ratio impaired spirometry with or without restrictive spirometric abnormality. SCIENTIFIC REPORTS. 2023. 13. 1
2021/11/21 - APSR JRS Young Scientist Award The role of circulatory high-mobility group box 1for predicting checkpoint inhibitor pneumonitis caused by anti-PD-1/PD-L1 antibody monotherapy